Log inSign up
AAOIFI No. 21 screening

Is CTOR halal?

Citius Oncology, Inc.

Doubtful

No clear verdict is possible for Citius Oncology, Inc. — data is insufficient or the case is contested in fiqh. As a precaution it is NOT included in the halal list.

Checked: 14 October 2026

Exchange

NASDAQ

Price

0.7679

Day

+2.94%

Market cap

$80.5M

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

What the company does

Citius Oncology (a Citius Pharma subsidiary) owns Lymphir, a drug for a rare T-cell lymphoma approved in 2024, with commercial launch just beginning. Its money is expected from drug sales.

What was checked

The AAOIFI standard has four steps: business activity first, then three financial ratios. Fail one and the stock is not halal.

  • Business activity

    No prohibited activity

  • Interest-bearing debt / market cap

    limit 30%

    Interest-bearing debt $10.21M ÷ 36-month average market cap $101.49M = 10.1%

    10.1%

    Pass

  • Cash & investments / market cap

    limit 30%

    Cash + interest-bearing securities $16.56M ÷ 36-month average market cap $101.49M = 16.3%

    16.3%

    Pass

  • Non-compliant income / total revenue

    limit 5%

    —

    No data

Figures from the company's filings (2026-06-30), USD. Market cap is a 36-month average (the S&P Shariah index approach), so a one-day price move does not flip the verdict. Today's market cap: $80.48M.

For information (AAOIFI 3/1 note): cash + receivables are 15.4% of total assets (2026-06-30). AAOIFI recommends tangible assets of at least one third — this figure does not affect the verdict, and other major screeners do not apply it either.

In the lists

In the S&P 500
Not in the S&P 500

Halal stocks in the same industry

The largest halal stocks in Drug Manufacturers - Specialty & Generic — for comparison.

Related articles

Halal is the first question. The second: when to enter?

Our scanner watches 1454 halal stocks around the clock and fires a signal with entry, TP and SL when a technical setup completes. The full signal history — with outcomes — is public.

This is neither investment advice nor a fatwa. Screening is based on public financial statements and AAOIFI standard No. 21; data may lag. For a personal decision consult your own scholar.

Earnings historyCTOR's next report date, EPS estimate vs actual for recent quarters and the post-earnings price move.View earnings →
Is CTOR halal? — Citius Oncology, Inc. AAOIFI screening result — Limitup